Clinical Trial Update: Efficacy Study of add-on Therapy With N-Acetylcysteine in Resistant Obsessive-compulsive Disorder [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating add-on N-acetylcysteine for treatment-resistant obsessive-compulsive disorder has completed, with the update summarizing its efficacy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: University of Sao Paulo | Conditions: Obsessive-Compulsive Disorder | Phase 2 | Status: COMPLETED